Investing Profile

David Schenkein

VCInvestor
General Partner at GV
gv.com/team/david-schenkein/Boston, Massachusetts
Photo of David Schenkein, General Partner at GV (Google Ventures)
Your Intro Paths to David Schenkein

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find David Schenkein on

cb
Current Investing Position
GV (Google Ventures) General Partner
Investment Range
$250K - $50.0M
Sweet Spot
$25.0M
Investments On Record
12
Current Fund Size
$8B

David Schenkein is on these Sector & Stage Rankings

David Schenkein's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Delphia Therapeutics
Series AMay 2024$67M
$67M
Cerevance
Series BApr 2024$47M
Series BFeb 2023$51M
Series BApr 2020$65M
$160M
Co-investors: Kouki Harasaki (Bioluminescence Ventures), Laurence Barker (SV Health Investors), Jason Lettmann (Morgenthaler Ventures), Bill Gates
EpiBiologics
Series AJul 2023$23M
$96M
Co-investors: Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures), Alaa Halawa
Aera Therapeutics
Series AFeb 2023
Series BFeb 2023$190M
$190M
Co-investors: Issi Rozen (GV (Google Ventures)), Josh Wolfe (Lux Capital), Robert Nelsen (ARCH Venture Partners)
Leyden Labs
Series BJan 2022$140M
Series AMar 2021$47M
$260M
Co-investors: Stephen Knight (F-Prime Capital Partners), Nisa Leung (Qiming Venture Partners), Brook Byers (Kleiner Perkins)
Prime Medicine
Series BJul 2021$200M
Series AOct 2019$120M
$320M
Co-investors: Stephen Knight (F-Prime Capital Partners), Neil Sirni (Arrive), Stephen Francis (Arrive), Robert Nelsen (ARCH Venture Partners)
Encoded Therapeutics
Series DJul 2020$140M
$240M
Co-investors: Greg Yap (Menlo Ventures)